A new study published in Hypertension, a peer-reviewed journal of the American Heart Association, challenges the long-held belief that menopause is the primary cause of increased aortic stiffness and pulse pressure in women after midlife. The research, based on data from the Framingham Heart Study, indicates that the shift from falling to rising pulse pressure occurs about two decades before menopause, suggesting that aortic structural changes, rather than hormonal shifts, may be the driving force.
Pulse pressure is the difference between systolic and diastolic blood pressure. A wider pulse pressure indicates that the aorta, the body's largest artery, is becoming stiffer and less flexible, which increases the risk of heart disease, dementia, and kidney disease. The study found that pulse pressure reached its lowest point and began to rise in women around their late 30s, compared to late 40s in men. This transition occurred regardless of whether women experienced early, average, or late menopause.
"Many people believe that the change in pulse pressure is linked to the hormonal shifts caused by menopause," said study senior author Gary F. Mitchell, M.D. "Here, we are evaluating whether the timing of this change is connected to menopause timing, and to our huge surprise, our results suggest that factors other than the timing of the final menstrual period were likely involved in the accelerated increase in pulse pressure in women after midlife."
The implications are significant for clinical practice. Wide pulse pressure is an independent risk factor for cardiovascular disease, yet it is not currently included in blood pressure management guidelines. "Healthcare professionals should definitely consider pulse pressure in middle-aged and older patients – especially women – with high blood pressure," Mitchell said. "Because women's overall heart disease risk is lower, they are often told that a blood pressure that is 'borderline' can just be watched. However, women and their doctors should sound the alarm if pulse pressure is higher than 60 mm Hg and track it over time."
The study analyzed 6,760 women and 3,248 men from the Framingham Heart Study, spanning 14 years. Women were grouped by self-reported age at menopause. The findings highlight that vascular aging may begin years before menopause. "We shouldn't wait until menopause to start thinking about cardiovascular health," said Samar R. El Khoudary, Ph.D., M.P.H., FAHA, who was not involved in the study. "By the time a woman reaches her final menstrual period, vascular changes may already have been underway for years."
According to the American Heart Association, the study underscores the need for early monitoring of pulse pressure, particularly in women. Tailored treatment approaches may be necessary because high blood pressure with wide pulse pressure is less responsive to standard medications. The research adds to the growing evidence that midlife is a critical window for identifying and intervening in cardiovascular risk.
Limitations of the observational study include reliance on self-reported menopause age and a predominantly white European descent sample, which may limit generalizability. However, the findings could lead to updated clinical guidelines that incorporate pulse pressure as a routine measure for assessing heart disease risk in midlife women.
